Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Price (688336.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

613,780,000

(0.4873)%

Sunshine Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $15.22-28.95
  • Market Cap 17.83B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Yan Li Liu
  • IPO Date: July, 22, 2020
  • Country: CN
  • Currency: CNY
  • Headquaters: No Data
  • Employees: 965

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation